MeSH tree: C20.111.197
Direct oral anticoagulants (DOACs) are a common treatment for patients with a wide variety of cardiovascular conditions. DOACs are the preferred treatment over vitamin K antagonists (VKAs) for many patients with atrial fibrillation ...
Feb 23, 2024
0
50
Blood clots and pregnancy loss are commonly recognized features of antiphospholipid syndrome, but thrombocytopenia is the third most prevalent symptom, impacting up to half of antiphospholipid syndrome patients.
Feb 8, 2024
0
39
A new study by Hospital for Special Surgery (HSS) investigators has found that an initial high-risk antibody profile for antiphospholipid syndrome (APS) tended to remain high in pediatric patients. The results were presented ...
Nov 13, 2023
0
19
Antiphospholipid syndrome (APS) is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such ...
Oct 30, 2023
0
44
A research group has found that novel autoantibodies that had been found to cause thrombosis and other conditions in joint research conducted by Kobe and Osaka universities in 2015, are also implicated in pregnancy disorders, ...
Aug 28, 2023
0
37
While antibodies normally help fight off infections, "autoantibodies" contribute to autoimmune diseases by recognizing and attacking a person's own body. Patients with autoimmune diseases have long been known to develop, ...
Apr 5, 2023
0
53
Antiphospholipid syndrome is a understudied autoimmune disease that is nevertheless a leading causes of deadly blood clots and late-term pregnancy loss. An international study led by the University of Michigan researchers ...
Mar 29, 2023
0
74
Antiphospholipid syndrome is an autoimmune disease that preferentially affects women. Patients with APS are typically given different medications to reduce their risk of blood clotting and help normalize lab values such as ...
Dec 23, 2022
0
89
The Geneva University Hospitals (HUG), the University of Geneva (UNIGE) and their spin-off Endotelix have created a possible target molecule for the antibodies responsible for antiphospholipid syndrome. This discovery will ...
Nov 1, 2022
0
23
